Syndax Pharmaceuticals Inc at Barclays Global Healthcare Conference Transcript
First and foremost, for all those in the audience and listening on the webcam on the presentation. It's a pleasure to have everyone back in person, management, investors, et cetera. So it's fantastic to having your support and enthusiasm for this event after 2 years, we're kind of coming back to norm, and my name is Peter Lawson. I'm 1 of the biotech analysts. I'll be hosting this fireside chat with Syndax. And I just want to thank Michael Metzger, CEO from Syndax. And I guess the first thing, I think, Michael, you can just talk through the kind of corporate overview, maybe of how you differentiate within the space and how the year has been for Syndax.
Yes. Well, first of all, thank you, Peter. Thanks to Barclays for inviting us to speak today, and it's nice to be back in person finally after 2 years of doing Zoom meetings. But let me first start off. Do we have the slides? Corporate didn't...
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
